SCHEMBL14465321

SCHEMBL14465321

CCOC(=O)c1cc2cc[nH]c2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
MAPK14 Q16539 3/20 0.50
MAPT P10636 2/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
JAK2 O60674 1/20 0.47
JAK3 P52333 1/20 0.47
KMT2A Q03164 1/20 0.47
MAOA P21397 1/20 0.46
ALDH1A1 P00352 4/20 0.46
GAA P10253 2/20 0.46
CTNNB1 P35222 1/20 0.45
WNT3A P56704 1/20 0.45
HPGD P15428 3/20 0.45
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6419304 0.87 MAOA (0.51) KDM4EMAPTLMNAJAK2JAK3
SCHEMBL27980556 0.85 MAPK14 (0.51) MAPK14MAPTPOLBKMT2AGAA
SCHEMBL12287690 0.84 MAOA (0.52) KDM4EMAPTSMN1; SMN2JAK2JAK3
SCHEMBL10289638 0.83 JAK2 (0.48) KDM4EJAK2JAK3KMT2AMAOA
SCHEMBL5538390 0.83 KDM4E (0.48) KDM4EMAPTLMNAPOLBSMN1; SMN2
SCHEMBL14465575 0.82 ALOX15 (0.50) KDM4EJAK2JAK3KMT2AMAOA
SCHEMBL16858478 0.82 GPR84 (0.49) KDM4EJAK2JAK3KMT2AMAOA
SCHEMBL397748 0.82 JAK2 (0.50) KDM4EJAK2JAK3KMT2AMAOA
SCHEMBL6419306 0.82 KDM4E (0.49) KDM4ESMN1; SMN2JAK2JAK3KMT2A
SCHEMBL4500812 0.81 ALDH1A1 (0.58) KDM4EMAPK14MAPTPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007081335-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS MERCK & CO., INC. (US) 2007-07-19 WO disclosed